Therapeutics Articles
From genetic assessment and prediction modeling to the study of genetics and genomics and the formulation of palliative care and self-management plans, the search for better cancer treatment and care is progressing rapidly.
Treatment for this difficult-to-diagnose form of hemophilia has to be individualized for each patient, but the prognosis is often good.
With options ranging from new web-based applications to electronic medication reminders, physicians may need to think outside the pillbox when it comes to encouraging medication adherence.
Diabetes is a full-blown epidemic in this country. But recent research is vastly changing our understanding of this life-threatening disease and providing new clues about how to treat and, possibly, even cure it.
Finally, there are more options for the unique bleeding disorder, von Willebrand disease.
As specialty pharmaceuticals are prescribed more frequently to treat more common diseases, the number of them under development and expected to be approved by the FDA in the next several years is surpassing that of other categories of drugs.
Research advances sparked by the Human Genome Project may soon significantly affect the practice, prescription and production of medicine.
Scientists are working on a variety of molecular and imaging diagnostics to advance the early detection rate of cancer.
Scientists around the world are working to improve upon and create new therapeutic options for hemophiliacs.
With the FDA approval of SCIG therapy in 2006, many patients now have the choice between SCIG and IVIG infusions. Understanding the differences between the two treatment modalities will help healthcare providers recommend the right one for their patients.